Hanks, B. A., Suhocki, P. V., DeLong, D. M., Doan, P. L., Liu, E., Tsai, A. L., … Morse, M. A. (2008). The efficacy and tolerability of transarterial chemo-embolization (TACE) compared with transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC). Journal of Clinical Oncology, 26(15_suppl), 4595–4595. https://doi.org/10.1200/jco.2008.26.15_suppl.4595

Hanks, B. A., P. V. Suhocki, D. M. DeLong, P. L. Doan, E. Liu, A. L. Tsai, C. T. Burke, S. A. Bernard, B. H. O’Neil, and M. A. Morse. “The efficacy and tolerability of transarterial chemo-embolization (TACE) compared with transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC).” Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 4595–4595. https://doi.org/10.1200/jco.2008.26.15_suppl.4595.

Hanks BA, Suhocki PV, DeLong DM, Doan PL, Liu E, Tsai AL, et al. The efficacy and tolerability of transarterial chemo-embolization (TACE) compared with transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC). Journal of Clinical Oncology. 2008 May 20;26(15_suppl):4595–4595.

Hanks, B. A., et al. “The efficacy and tolerability of transarterial chemo-embolization (TACE) compared with transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC).” Journal of Clinical Oncology, vol. 26, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2008, pp. 4595–4595. Crossref, doi:10.1200/jco.2008.26.15_suppl.4595.

Hanks BA, Suhocki PV, DeLong DM, Doan PL, Liu E, Tsai AL, Burke CT, Bernard SA, O’Neil BH, Morse MA. The efficacy and tolerability of transarterial chemo-embolization (TACE) compared with transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008 May 20;26(15_suppl):4595–4595.